Insider · CIK 0001578407

Bain Linda

Reports to the SEC for 7 companies · LONDON

sec.gov

Transactions

Companies

Filings

CIK

0001578407

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-29	AUTLAutolus Therapeutics plc · Restricted Share UnitsA Award	Director	AAward	+31.7K sh	—	—	31,667
2026-06-29	AUTLAutolus Therapeutics plc · Share Option (Right to Buy)A Award	Director	AAward	+47.5K sh	—	—	47,500
2026-06-24	ARVNARVINAS, INC. · Stock Option (right to buy)A Award	Director	AAward	+22.7K sh	—	—	22,714
2026-06-24	ARVNARVINAS, INC.A Award	Director	AAward	+15.5K sh	—	—	41,572
2025-06-25	ARVNARVINAS, INC.A Award	Director	AAward	+16K sh	—	—	26,045
2025-06-25	ARVNARVINAS, INC. · Stock Option (right to buy)A Award	Director	AAward	+23.1K sh	—	—	23,105
2024-05-29	ARVNARVINAS, INC.A Award	Director	AAward	+5,899 sh	—	—	10,020
2024-05-29	ARVNARVINAS, INC. · Stock Option (right to buy)A Award	Director	AAward	+9,070 sh	—	—	9,070
2023-06-15	ARVNARVINAS, INC.A Award	Director	AAward	+4,121 sh	—	—	4,121
2023-06-15	ARVNARVINAS, INC. · Stock Option (right to buy)A Award	Director	AAward	+12.8K sh	—	—	12,787
2023-03-28	Codiak BioSciences, Inc.S Sale	Chief Financial Officer	SSale	−13.4K sh	$0.17	−$2,270.652	0
2023-02-17	Codiak BioSciences, Inc.S Sale	Chief Financial Officer	SSale	−2,570 sh	$0.59	−$1,521.954	13,412
2023-02-16	Codiak BioSciences, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+7,613 sh	—	—	15,982
2023-02-16	Codiak BioSciences, Inc.Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−7,613 sh	—	—	15,224
2023-01-24	Codiak BioSciences, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+185K sh	—	—	185,000
2023-01-20	Codiak BioSciences, Inc.S Sale	Chief Financial Officer	SSale	−1,880 sh	$0.57	−$1,081	3,120
2023-01-19	Codiak BioSciences, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+5,000 sh	—	—	5,000
2023-01-19	Codiak BioSciences, Inc.Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−5,000 sh	—	—	10,000
2022-09-16	Codiak BioSciences, Inc.Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+80K sh	—	—	80,000
2022-08-17	Codiak BioSciences, Inc.S Sale	Chief Financial Officer	SSale	−2,364 sh	$2.21	−$5,231.296	8,369
2022-08-16	Codiak BioSciences, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+7,613 sh	—	—	10,733
2022-08-16	Codiak BioSciences, Inc.Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−7,613 sh	—	—	22,837
2022-06-16	ARVNARVINAS, INC. · Stock Option (right to buy)A Award	Director	AAward	+10.2K sh	—	—	10,192
2022-02-16	Codiak BioSciences, Inc.Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+30.5K sh	—	—	30,450
2022-02-16	Codiak BioSciences, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+20.3K sh	—	—	20,300
2022-01-27	VBI Vaccines Inc/BCOption (Right to Buy Common Shares)A Award	Director	AAward	+75K sh	—	—	75,000
2022-01-19	Codiak BioSciences, Inc.Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+15K sh	—	—	15,000
2022-01-19	Codiak BioSciences, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+65K sh	—	—	65,000
2021-07-01	VBI Vaccines Inc/BCOption (Right to Buy Common Shares)A Award	Director	AAward	+250K sh	—	—	250,000
2021-06-08	ARVNARVINAS, INC. · Stock Option (right to buy)A Award	Director	AAward	+7,511 sh	—	—	7,511
2021-01-22	Codiak BioSciences, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+58K sh	—	—	58,000
2020-06-10	ARVNARVINAS, INC. · Stock Option (right to buy)A Award	Director	AAward	+24K sh	—	—	24,000
2015-08-21	Adverum Biotechnologies, Inc.A Award	Chief Financial Officer	AAward	+32.9K sh	—	—	41,930
2015-06-12	Adverum Biotechnologies, Inc.S Sale	Chief Financial Officer	SSale	−3,500 sh	$39.94	−$140K	9,000
2015-06-12	Adverum Biotechnologies, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+3,500 sh	$3.15	+$11K	12,500
2015-06-12	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−3,500 sh	—	—	233,000
2015-05-13	Adverum Biotechnologies, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+285 sh	$3.15	+$897.75	9,285
2015-05-13	Adverum Biotechnologies, Inc.S Sale	Chief Financial Officer	SSale	−285 sh	$34.94	−$9,958.727	9,000
2015-05-13	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−285 sh	—	—	236,500
2015-05-11	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−715 sh	—	—	236,785
2015-05-11	Adverum Biotechnologies, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+715 sh	$3.15	+$2,252.25	9,715
2015-05-11	Adverum Biotechnologies, Inc.S Sale	Chief Financial Officer	SSale	−715 sh	$34.91	−$25K	9,000
2015-05-04	Adverum Biotechnologies, Inc.S Sale	Chief Financial Officer	SSale	−2,500 sh	$31.59	−$79K	9,000
2015-05-04	Adverum Biotechnologies, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+2,500 sh	$3.15	+$7,875	11,500
2015-05-04	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−2,500 sh	—	—	237,500
2015-04-21	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+25K sh	—	—	25,000
2015-04-21	Adverum Biotechnologies, Inc.A Award	Chief Financial Officer	AAward	+9,000 sh	—	—	9,000
2014-03-03	bluebird bio, Inc.Stock Option (right to buy)M Exercise/Conversion	VP, Fin. & Business Operations	MExercise/Conversion	−2,500 sh	—	—	48,516
2014-03-03	bluebird bio, Inc.M Exercise/Conversion	VP, Fin. & Business Operations	MExercise/Conversion	+2,500 sh	$2.09	+$5,225	2,500
2014-03-03	bluebird bio, Inc.S Sale	VP, Fin. & Business Operations	SSale	−2,500 sh	$24.79	−$62K	0

Recent filings

Accepted (ET)
Jul 14
Bain Linda0001730463-26-000095
SEC(opens sec.gov)
Jun 264
Bain Linda0001628280-26-045781
SEC(opens sec.gov)
Jun 274
Bain Linda0001655759-25-000118
SEC(opens sec.gov)
May 314
Bain Linda0001655759-24-000089
SEC(opens sec.gov)
Jun 204
Bain Linda0001655759-23-000060
SEC(opens sec.gov)
Mar 304
Bain Linda0000950170-23-011028
SEC(opens sec.gov)
Feb 214
Bain Linda0000899243-23-005697
SEC(opens sec.gov)
Jan 264
Bain Linda0000899243-23-002753
SEC(opens sec.gov)
Jan 234
Bain Linda0000899243-23-002405
SEC(opens sec.gov)

Companies

Address

THE MEDIAWORKS, WHITE CITY C/O AUTOLUS THERAPEUTICS PLC

LONDON, W12 7FP